Research Article

The Efficacy of Traditional Chinese Medicine Shoutai Pill Combined with Western Medicine in the First Trimester of Pregnancy in Women with Unexplained Recurrent Spontaneous Abortion: A Systematic Review and Meta-Analysis

Table 1

The basic characteristics of the included studies.

First author and yearSample size ()Age (y)Gestational age (d)TCM syndrome differentiationTimes of abortions ()Definition of miscarriageDefinition of live birthIntervention timeIntervention measuresDuration of interventionMain outcomes

Guo 2018T: 54
C: 54
T:
C:
T: NR
C: NR
NRT:
C:
Pregnancy loss before 16 weeksDelivery of a live infant after 28 weeksNRT: modified STP (1/dose/day) + C
C: dydrogesterone (10 mg, bid, po)
Until miscarriage or the 16th weeks①②③
He 2018T: 30
C: 30
T:
C:
T:
C:
Kidney deficiency and blood stasisT:
C:
Pregnancy loss before 12 weeksDelivery of a live infant after 37 weeksPregnancy confirmed by β-HCGT: modified STP (1/dose/day) + C
C: progesterone capsule (100 mg, bid, po)
3 months①②③
Huang 2016T: 31
C: 30
T:
C:
T:
C:
Spleen and kidney deficiencyT:
C:
Pregnancy loss before 12 weeksNRPregnancy confirmed by ultrasoundT: modified STP (1/dose/day) + C
C: progesterone injection (20 mg, qd, im)
14 days
Li 2017T: 42
C: 42
T:
C:
T:
C:
NRT:
C:
Pregnancy loss before 12 weeksNRPregnancy confirmed by β-HCGT: modified STP (1/dose/day) + C
C: dydrogesterone (10 mg, bid, po)
NR①③④
Lu 2016T: 39
C: 37
T:
C:
T:
C:
NRT:
C:
Pregnancy loss before 20 weeksNRPregnancy confirmed by ultrasoundT: modified STP (1/dose/day) + C
C: dydrogesterone (10 mg, bid, po)
Until miscarriage or the 16th weeks①⑤
Mo 2018T: 20
C: 20
T:
C:
T: NR
C: NR
Kidney deficiency and blood stasisT:
C:
NRDelivery of a live infant after 37 weeksPregnancy confirmed by β-HCGT: modified STP (1/dose/day) + C
C: progesterone capsule (100 mg, bid, po) + dydrogesterone (10 mg, bid, po)
7 days for a course of treatment②③④
Tian 2019T: 40
C: 40
T:
C:
T: NR
C: NR
NRT:
C:
Pregnancy loss before 12 weeksNRPregnancy confirmed by ultrasoundT: STP (1/dose/day) + C
C: dydrogesterone
(10 mg, q12h, po)
Until miscarriage or more than the 12th weeks①③
Wang 2016T: 75
C: 75
T:
C:
T:
C:
NRT: NR
C: NR
Pregnancy loss before 12 weeksNRPregnancy confirmed by ultrasoundT: STP (1/dose/day) + C
C: allogenic lymphocyte + dydrogesterone (10 mg, bid, po)
Until miscarriage or the 12th weeks
Wei 2017T: 30
C: 30
T:
C:
T:
C:
Kidney deficiency and blood stasisT:
C:
Pregnancy loss before 12 weeksDelivery of a live infant after 37 weeksPregnancy confirmed by β-HCGT: modified STP (1/dose/day) + C
C: progesterone capsule (100 mg, bid, po)
NR①②③④
Xie 2016T: 36
C: 36
T:
C:
T:
C:
Kidney deficiency and blood stasisT:
C:
Pregnancy loss before 12 weeksNRNRT: modified STP (1/dose/day) + C
C: dydrogesterone (10 mg, bid, po)
28 days①③④⑤
Yuan 2015T: 40
C: 40
T:
C:
T: NR
C: NR
Kidney deficiency and blood stasisT:
C:
Pregnancy loss before 12 weeksNRPregnancy confirmed by ultrasoundT: modified STP (1/dose/day) + C
C: dydrogesterone (10 mg, bid, po)
Until miscarriage or the 12th weeks①⑤
Zheng 2019T: 23
C: 22
T:
C:
T: NR
C: NR
NRT:
C:
Pregnancy loss before 28 weeksDelivery of a live infant after 28 weeksNRT: STP (1/dose/day) + C
C: progesterone injection (20 mg, qd, im) + dydrogesterone (10 mg, bid, po) + low-molecular weight heparin sodium (5000 iu, qd, h)
Until miscarriage or the 20th weeks①②③

T: trial group; C: control group; NR: not reported; ①: the incidence of early pregnancy loss; ②: the incidence of live birth; ③: TCM syndromes and symptoms; ④: serum D-dimer level; ⑤: adverse events.